Skip to content
Sign up to our: Newsletter | Newsfeeds

New cancer drug to be available in Wales

Nivolumab, a new life-extending drug to treat some forms of lung cancer is to be made routinely available in Wales, the Welsh Goverment has announced.
Monday 23 October 2017

A patient access scheme between NHS Wales and the manufacturer, Bristol-Myers Squibb, means that it will be available to treat some people with advanced non-small cell lung cancer, if they have already been treated with chemotherapy.

Nivolumab, also known as Opdivo®, will be available where clinically appropriate no later than 60 days after the agreement was signed.

Health Secretary, Vaughan Gething said:

“I’m pleased NHS Wales has been able to reach an agreement with the manufacturer, which will make the drug routinely available in Wales, to patients who will benefit. 

“Our £80m New Treatment Fund launched in January this year supports faster and more consistent access to medicines recommended by NICE and the AWMSG. This includes new cancer treatments  – such as Nivolumab – even where the NICE recommendation is subject to a detailed agreement with the manufacturer.”  

 

Share

Delicious
Delicious
Digg
Digg
reddit
reddit
Facebook
Facebook
 
About social bookmarking

Related

Tags

Health and social services 23 October 2017 Programme for Government - Healthcare Mid Wales North Wales South East Wales South West Wales
 
 

News by date

 
November 2017
M T W T F S S
<< Oct    
    1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30      
Follow us on